Featured Jobs
|
Pattison Pension
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Regional Vice President, Sales MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
MAP Retirement
|
|
Sentinel Group
|
|
BPAS
|
|
MAP Retirement
|
|
Retirement Relationship Manager MAP Retirement
|
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
FTC Pharma Merger Digest May Offer Policy Clues
Law360; registration or subscription required 
June 16, 2023 "The summary includes remarks by FTC Chair Lina Khan, questioning whether additional considerations beyond traditional horizontal overlap theories should be analyzed when evaluating deals in the pharmaceutical context -- including more closely examining remedies, potential innovation and prior bad acts by the parties to a deal.... The topics discussed broadly fell into several categories ... [1] concentration in the pharmaceutical industry, [2] remedies in pharmaceutical mergers, and [3] examination of prior bad acts in merger review. This article discusses and analyzes these topics." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |